Please note: The information displayed on this page might be outdated.
Philogen: Developer of biopharmaceuticals for the treatment of angiogenesis-related disorders. The company is engaged in the discovery and development of novel biopharmaceutical products and offers antibody derivatives for the treatment of certain cancers cancer, rheumatoid arthritis and age-related macular degeneration.
Phase III, Phase l or ll, Pre-Clinical Stage
100MM - 500MM
Antibodies, Cell Therapy
Via Bellaria, 35
Company Participants at European Biotech Investor Day 2020
- Dario Neri